Skip to content

PTHS PTHS Shares issued for payment of accrued interest

Shares issued for payment of accrued interest at other companies

Lightbridge logo
LightbridgeLTBR
$3.75K0.0%
Aptera Motors Corp.
 logo
Aptera Motors Corp. SEV
$175.75K
LiveOne, Inc. logo
LiveOne, Inc.LVO
$1.32M
JAN
Janus Living JAN
$95K
JFB Construction Holdings Class A Common Stock logo
JFB Construction Holdings Class A Common StockJFB
$1.61M
Precigen logo
PrecigenPGEN
$526K-0.2%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept pths:SharesIssuedForPaymentOfAccruedInterest.

The official record: PTHS’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's shares issued for payment of accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's shares issued for payment of accrued interest?
PTHS (PTHS) reported shares issued for payment of accrued interest of $0 in Q4 2025.
How has PTHS's shares issued for payment of accrued interest changed year-over-year?
PTHS's shares issued for payment of accrued interest decreased by 100.0% year-over-year, from $750 to $0.
What does shares issued for payment of accrued interest mean?
This metric quantifies the value of equity shares issued to creditors in lieu of cash payments for accrued interest expenses. It serves as a liquidity management tool, allowing the company to preserve cash for operational or research activities while fulfilling debt service obligations. A high frequency of this activity may indicate cash flow constraints or a preference for preserving capital for clinical development.